Translational Psychedelic Research Program

The Translational Psychedelic Research (TrPR) Program brings together scientists and care providers across disciplines to understand how psilocybin, LSD, ketamine, MDMA, and related compounds impact the brain and other organ systems.

Abstract drawing of faces

Translational Psychedelic Research Program

The Translational Psychedelic Research (TrPR) Program brings together scientists and care providers across disciplines to investigate psychedelic drugs as potentially transformative treatments for the most serious unmet medical needs. We are dedicated to understanding how psychedelics work in order to best optimize and personalize these treatments to be maximally safe, effective, and accessible for patients.

Abstract drawing of faces

in collaboration with:

in partnership with:


Seguridad y eficacia del tratamiento con psilocibina para la depresión en el trastorno bipolar 2
Read More
Recruiting Now
Psilocybin Therapy for Depression and Anxiety in Parkinson’s Disease: A Pilot Study
Read More
Not Open to Recruitment
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Read More
Recruiting Now
Safety and Efficacy of Psilocybin Treatment for Depression in Bipolar 2 Disorder
Read More
Recruiting Now
Randomized Clinical Trial of Psilocybin for Depression (Usona Institute)
Read More
Recruitment Closed
Randomized Clinical Trial of Psilocybin for Chronic Low Back Pain
Read More
Recruiting Now
Effects of Psilocybin Therapy on Sleep and Thermoregulation
Read More
A Mixed-Methods Study of Psilocybin Use Among Adults with Bipolar Affective Disorder
Read More

Our Team

We’re a network of researchers with expertise spanning neuroscience, multiple medical specialties, nursing, and psychology.


Joshua Woolley, MD, PhD
Ellen Bradley, MD
Associate Director
Aoife O’Donovan, PhD
Amanda Downey, MD
Medical Team Lead
Katiah Llerena, PhD
Director of Assessments
Connie Ludwig, PhD
Assessment Consultant
Holly Hamilton, PhD
Andrew Penn, RN, MS, NP
Ray Rosen, PhD
Marissa Raymond-Flesch, MD, MPH


Gisele Fernandes, MFT
Director of Facilitation
Alex Theberhe, MFT
Aliss Ching Chieh Wang
Gianni Glick, MD
Ayala Kalisher
Andrew Penn, RN, MS, NP
Linnae Ponte, LMFT
Kari Bar
Luara Venturi
Taylor Simon
Ashley Kellem

Medical Team

Amanda Downey, MD
Medical Team Lead
Cindy Lau, NP
Gianni Glick, MD
Fletcher Bell, MD
Michael Dinh, MD

Core Collaborators

David Gard, PhD
Boris Heifets, MD, PhD
Erin Michalak, PhD
Ashley Mason, PhD
Andrew Krystal, MD
Jill Ostrem, MD
Andrea Gomez, PhD


Steve Pratscher, PhD
Leehe Peled-Avron, PhD
Emma Morton, PhD
Jacob Aday, PhD
Parker Kelley, PhD

Graduate Students

Sheila M. Thompson, BS
Sarah Van De Weert, MA
Sam Loomis, MA
Jacqueline Golub, MA
Julia Fox, MA

Staff & Research Assistants

Kim Sakai
Program Manager
Lisa Fredenburg, MS
Sr. Study Coordinator
Zachary Busby
Sr. Study Coordinator
Jake Gibson
Study Coordinator
Amber McKernan
Study Coordinator
Jerusalem Nerayo
Study Coordinator
Cesar Molina
Study Coordinator
Jason Young
Admin. Assistant

Work with us

Developing psychedelic treatments is an interdisciplinary challenge. We welcome a wide range of people with expertise in science and health care, knowing that different perspectives create a stronger and more creative team. We aim to promote diversity, equity, and inclusion in line with this statement.

Thinking about participating in a study or want to learn more?

Contact us at

Interested in working with us as a volunteer research assistant / intern?

Please complete our TrPR Volunteer Application

Seeking paid work at TrPR?

See our current job listings for research staff

Post-doc applicants - please forward your resume/CV and cover letter to